Desensitization to Allopurinol in Localized and Systemic Hypersensitivity Reactions

@inproceedings{SegorbeLus2013DesensitizationTA,
  title={Desensitization to Allopurinol in Localized and Systemic Hypersensitivity Reactions},
  author={Segorbe-Lu{\'i}s},
  year={2013}
}
  • Segorbe-Luís
  • Published 2013
Allopurinol (4-hidroxipirazolol piramidine) is the first line therapy employed to treat hyperuricemia. It is an inhibitor of the enzymexanthine oxidase which is responsible for the successive oxidation of hypoxanthine andxanthine, resulting in the production of uric acid [1]. In addition to blocking uric acid production it may also inhibit purine synthesis [2]. Although it is a well-tolerated drug, there are descriptions of HSreactions to treatment with variable degree of incidence and severity… CONTINUE READING
1 Citations
28 References
Similar Papers

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 28 references

286-287

  • A Umpiérrez, J Cuesta-Herranz, M De Las Heras, M Lluch-Bernal, E Figueredo, 101 et al. Successful desensitization of a fixed drug Immunol
  • Citation: Gomes R, Ribeiro F, Faria E, Loureiro C…
  • 2013
1 Excerpt

Alopurinol : experiênciaemdessensibilização , Rev Port Imunoalergologia

  • SL Silva, AS Santos, AL Pregal, E Pedro, MB Ferreira
  • 2004

Similar Papers

Loading similar papers…